SEARCH

SEARCH BY CITATION

References

  • Biffi A, Maron BJ, Di Giacinto B, Porcacchia P, Verdile L, Fernando F, Spataro A, Culasso F, Casasco M & Pelliccia A (2008). Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. Am J Cardiol 101, 17921795.
  • Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C, Burashnikov E, Matsuo K, Wu YS, Guerchicoff A, Bianchi F, Giustetto C, Schimpf R, Brugada P & Antzelevitch C (2004). Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 3035.
  • Brunet S, Aimond F, Li H, Guo W, Eldstrom J, Fedida D, Yamada KA & Nerbonne JM. (2004). Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles. J Physiol 559, 103120.
  • Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, Solda PL, Davey P, Ormerod O, Forfar C, et al . (1992). Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85, 21192131.
  • DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M & Muslin AJ (2006). Akt1 is required for physiological cardiac growth. Circulation 113, 20972104.
  • Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713719.
  • Guo W, Jung WE, Marionneau C, Aimond F, Xu H, Yamada KA, Schwarz TL, Demolombe S & Nerbonne JM (2005). Targeted deletion of Kv4.2 eliminates Ito,f and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res 97, 13421350.
  • Guo W, Li H, Aimond F, Johns DC, Rhodes KJ, Trimmer JS & Nerbonne JM (2002). Role of heteromultimers in the generation of myocardial transient outward K+ currents. Circ Res 90, 586593.
  • Haider AW, Larson MG, Benjamin EJ & Levy D (1998). Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32, 14541459.
  • Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N & Schuler G (2000). Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342, 454460.
  • Hannan RD, Jenkins A, Jenkins AK & Brandenburger Y (2003). Cardiac hypertrophy: a matter of translation. Clin Exp Pharmacol Physiol 30, 517527.
  • Kaab S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D & Tomaselli GF (1998). Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98, 13831393.
  • Kong W, Po S, Yamagishi T, Ashen MD, Stetten G & Tomaselli GF (1998). Isolation and characterization of the human gene encoding Ito: further diversity by alternative mRNA splicing. Am J Physiol Heart Circ Physiol 275, H19631970.
  • Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR & Chien KR (2001). A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of Ito and confers susceptibility to ventricular tachycardia. Cell 107, 801813.
  • Lachance D, Plante E, Bouchard-Thomassin AA, Champetier S, Roussel E, Drolet MC, Arsenault M & Couet J (2009). Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload. Circ Heart Fail 2, 437445.
  • London B, Guo W, Pan X, Lee JS, Shusterman V, Rocco CJ, Logothetis DA, Nerbonne JM & Hill JA (2001). Targeted replacement of Kv1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of IK,slow and resistance to drug-induced QT prolongation. Circ Res 88, 940946.
  • Marionneau C, Brunet S, Flagg TP, Pilgram TK, Demolombe S & Nerbonne JM (2008). Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy. Circ Res 102, 14061415.
  • Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, Lei M, Escande D & Demolombe S (2005). Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562, 223234.
  • Mayet J, Kanagaratnam P, Shahi M, Senior R, Doherty M, Poulter NR, Sever PS, Handler CE, Thom SA & Foale RA (1999). QT dispersion in athletic left ventricular hypertrophy. Am Heart J 137, 678681.
  • Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA & Thom SA (1996). Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 28, 791796.
  • McIntyre H & Fry CH (1997). Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium. J Cardiovasc Electrophysiol 8, 887894.
  • McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY & Jennings GL (2007). Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104, 612617.
  • McMullen JR & Jennings GL (2007). Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34, 255262.
  • McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM & Izumo S (2003). Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100, 1235512360.
  • Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, Irigoyen MC, Krieger EM, Krieger JE, Negrao CE & Brum PC (2008). Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol 104, 103109.
  • Mitchell GF, Jeron A & Koren G (1998). Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274, H747751.
  • Nabauer M, Beuckelmann DJ, Uberfuhr P & Steinbeck G (1996). Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93, 168177.
  • O’Neill BT, Kim J, Wende AR, Theobald HA, Tuinei J, Buchanan J, Guo A, Zaha VG, Davis DK, Schell JC, Boudina S, Wayment B, Litwin SE, Shioi T, Izumo S, Birnbaum MJ & Abel ED (2007). A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab 6, 294306.
  • Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlof B, Devereux RB & Okin PM (2004). QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 43, 10291034.
  • Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barletta MR, Gudapakkam S, Bosi G, Stramba-Badiale M & Jalife J (2005). A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96, 800807.
  • Putzke C, Wemhoner K, Sachse FB, Rinne S, Schlichthorl G, Li XT, Jae L, Eckhardt I, Wischmeyer E, Wulf H, Preisig-Muller R, Daut J & Decher N (2007). The acid-sensitive potassium channel TASK-1 in rat cardiac muscle. Cardiovasc Res 75, 5968.
  • Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL & Keating MT (1996). Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 384, 8083.
  • Sanguinetti MC, Jiang C, Curran ME & Keating MT (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81, 299307.
  • Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC & Izumo S (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19, 25372548.
  • Wang Z, Feng J, Shi H, Pond A, Nerbonne JM & Nattel S (1999). Potential molecular basis of different physiological properties of the transient outward K+ current in rabbit and human atrial myocytes. Circ Res 84, 551561.
  • Xu H, Barry DM, Li H, Brunet S, Guo W & Nerbonne JM (1999a). Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 α subunit. Circ Res 85, 623633.
  • Xu H, Guo W & Nerbonne JM (1999b). Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes. J Gen Physiol 113, 661678.
  • Zaritsky JJ, Redell JB, Tempel BL & Schwarz TL (2001). The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol 533, 697710.